GOSSAMER BIO, INC. Public Float
GOSSAMER BIO, INC. (GOSS) had Public Float of $270.80 million as of 2025-06-28, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-28: Entity Public Float $270.80M.
- 2024-06-28: Entity Public Float $197.40M.
- 2023-06-30: Entity Public Float $98.00M.
- 2022-06-30: Entity Public Float $541.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-28 | $270.80M 10-K · filed 2026-03-17 |
| 2024-06-28 | $197.40M 10-K · filed 2025-03-13 |
| 2023-06-30 | $98.00M 10-K · filed 2024-03-05 |
| 2022-06-30 | $541.30M 10-K · filed 2023-03-17 |
| 2021-06-30 | $516.90M 10-K · filed 2022-03-03 |
| 2020-06-30 | $774.80M 10-K · filed 2021-02-26 |
| 2019-06-28 | $947.80M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |